CerRx, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas (NCT02495415) | CerRx, Inc. | 2016-12-01 |
Track CerRx, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.